2022, Number 4
Localized scleroderma in a 10-year-old schoolgirl
Language: Spanish
References: 11
Page:
PDF size: 0. Kb.
ABSTRACT
Within the group of rheumatic diseases, scleroderma is one of those with the lowest frequency of presentation; being considered a rare disease by many authors. Although it has a predominance of affectation in adult patients, it sometimes occurs in pediatric ages, its localized forms being the most frequent forms of presentation. The objective of this report is to present the case of a 10-year-old schoolgirl, with a 3-year history of skin lesions, which was diagnosed, through clinical characteristics and results of pathological studies, as deep localized scleroderma. The case report is considered important to share with the medical community the basic elements related to the diagnosis and treatment of this disease, as an alternative to reducing the complications it generates.REFERENCES
Bedón-Galarza R, Rosero C, Cuadros F, Chávez Y, Abad-Sojos A, Veloz X. Criterios de clasificación de esclerosis sistémica, en una serie de casos de pacientes ecuatorianos. Rev Argent Dermatol. 2020 [acceso 26/04/2022];101(2):91-100. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S1851-300X2020000200091&lng=es2.
de la Fuente-Laso P, González-García J, Castaño-Rivero A, Gonzalvo-Rodríguez P, Rodríguez-Díaz E, Vázquez-Osorio I. Morfea profunda solitaria: Una forma infrecuente de esclerodermia localizada en la infancia. Caso clínico. Arch Argent Pediatr. 2019 [acceso 26/04/2022];117(2):e137-e41. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-00752019000200017&lng=es5.
Ruiz-Mejía O, Pimentel-Rangel J, Oribio-Gallegos JA, Valle de Lascuraín G, Esquivel-Vallejo A, Vega-España EA. Manejo ortopédico de la esclerodermia lineal localizada en niños: reporte de un caso. Acta Ortop Mex. 2019 [acceso 26/04/2022];33(4):261-4. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S2306-41022019000400261&lng=es6.
García Munitis P. Evaluación de tecnología sanitaria: informe de respuesta rápida: Tocilizumab para el tratamiento de la artritis idiopática juvenil poliarticular. Rev Argent Reumatolg. 2018 [acceso 02/05/2022];29(2):10-5. Disponible en: http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S2362-36752018000200004&lng=es11.